233 related articles for article (PubMed ID: 22074294)
21. Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.
Xiong Y; Mahmood A; Meng Y; Zhang Y; Zhang ZG; Morris DC; Chopp M
Ann N Y Acad Sci; 2012 Oct; 1270():51-8. PubMed ID: 23050817
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
Cavasin MA
Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration.
Mollinari C; Ricci-Vitiani L; Pieri M; Lucantoni C; Rinaldi AM; Racaniello M; De Maria R; Zona C; Pallini R; Merlo D; Garaci E
J Cell Sci; 2009 Nov; 122(Pt 22):4195-207. PubMed ID: 19861493
[TBL] [Abstract][Full Text] [Related]
24. Thymosin beta4 and cardiac repair.
Shrivastava S; Srivastava D; Olson EN; DiMaio JM; Bock-Marquette I
Ann N Y Acad Sci; 2010 Apr; 1194():87-96. PubMed ID: 20536454
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo.
Vorotnikova E; McIntosh D; Dewilde A; Zhang J; Reing JE; Zhang L; Cordero K; Bedelbaeva K; Gourevitch D; Heber-Katz E; Badylak SF; Braunhut SJ
Matrix Biol; 2010 Oct; 29(8):690-700. PubMed ID: 20797438
[TBL] [Abstract][Full Text] [Related]
26. Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.
Bollini S; Riley PR; Smart N
Expert Opin Biol Ther; 2015; 15 Suppl 1():S163-74. PubMed ID: 26094634
[TBL] [Abstract][Full Text] [Related]
27. Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions.
Sribenja S; Li M; Wongkham S; Wongkham C; Yao Q; Chen C
Cancer Invest; 2009 Dec; 27(10):1016-22. PubMed ID: 19909017
[TBL] [Abstract][Full Text] [Related]
28. Thymosin β4 limits inflammation through autophagy.
Renga G; Oikonomou V; Stincardini C; Pariano M; Borghi M; Costantini C; Bartoli A; Garaci E; Goldstein AL; Romani L
Expert Opin Biol Ther; 2018 Jul; 18(sup1):171-175. PubMed ID: 30063848
[TBL] [Abstract][Full Text] [Related]
29. Thymosin β4: a potential molecular target for tumor therapy.
Xiao Y; Chen Y; Wen J; Yan W; Zhou K; Cai W
Crit Rev Eukaryot Gene Expr; 2012; 22(2):109-16. PubMed ID: 22856429
[TBL] [Abstract][Full Text] [Related]
30. Thymosin β as an Actin-binding Protein with a Variety of Functions.
Kuzan A
Adv Clin Exp Med; 2016; 25(6):1331-1336. PubMed ID: 28028989
[TBL] [Abstract][Full Text] [Related]
31. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.
Philp D; Goldstein AL; Kleinman HK
Mech Ageing Dev; 2004 Feb; 125(2):113-5. PubMed ID: 15037013
[TBL] [Abstract][Full Text] [Related]
32. Reversal of second-hand cigarette smoke-induced impairment of corneal wound healing by thymosin beta4 combined with anti-inflammatory agents.
Yuan H; Ma C; Moinet L; Sato N; Martins-Green M
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2424-35. PubMed ID: 20019366
[TBL] [Abstract][Full Text] [Related]
33. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.
Sosne G; Christopherson PL; Barrett RP; Fridman R
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2388-95. PubMed ID: 15980226
[TBL] [Abstract][Full Text] [Related]
34. [The modern approach to wound treatment].
Komarcević A
Med Pregl; 2000; 53(7-8):363-8. PubMed ID: 11214479
[TBL] [Abstract][Full Text] [Related]
35. Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing, and the possible clinical utility of topically applied thymosin beta4.
Fine JD
Ann N Y Acad Sci; 2007 Sep; 1112():396-406. PubMed ID: 17468231
[TBL] [Abstract][Full Text] [Related]
36. Thymosin beta4 increases hair growth by activation of hair follicle stem cells.
Philp D; Nguyen M; Scheremeta B; St-Surin S; Villa AM; Orgel A; Kleinman HK; Elkin M
FASEB J; 2004 Feb; 18(2):385-7. PubMed ID: 14657002
[TBL] [Abstract][Full Text] [Related]
37. Biological activities of thymosin beta4 defined by active sites in short peptide sequences.
Sosne G; Qiu P; Goldstein AL; Wheater M
FASEB J; 2010 Jul; 24(7):2144-51. PubMed ID: 20179146
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.
Stark C; Taimen P; Tarkia M; Pärkkä J; Saraste A; Alastalo TP; Savunen T; Koskenvuo J
Ann N Y Acad Sci; 2012 Oct; 1269():117-24. PubMed ID: 23045979
[TBL] [Abstract][Full Text] [Related]
39. Thymosin beta 4 and the eye: the journey from bench to bedside.
Sosne G
Expert Opin Biol Ther; 2018 Jul; 18(sup1):99-104. PubMed ID: 30063853
[TBL] [Abstract][Full Text] [Related]
40. Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing.
Evans MA; Smart N; Dubé KN; Bollini S; Clark JE; Evans HG; Taams LS; Richardson R; Lévesque M; Martin P; Mills K; Riegler J; Price AN; Lythgoe MF; Riley PR
Nat Commun; 2013; 4():2081. PubMed ID: 23820300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
